GLP-1 agonists have taken center stage in the treatment of type 2 diabetes and obesity1, sparking intense demand and supply challenges. As stakeholders grapple with shortages and the emergence of compounded alternatives, it’s crucial to understand the current landscape and its implications for pharmacy benefits management.  Current Availability of GLP-1 Agonists  As of August 2024,…

Biosimilars offer a promising alternative to expensive biologic drugs like Humira, potentially reducing costs for patients and healthcare providers. Since the introduction of Amjevita in January 2023, the landscape for Humira biosimilars has evolved. This article explores recent market trends, the variety of available biosimilars, cost implications, and the opportunity for a Biosimilar Advantage Formulary℠.…

Balancing member satisfaction with cost-containment initiatives can be challenging. That’s why we make client and member service our priority. You and your clients will have peace of mind knowing members are being taken care of for any plan design you choose.   In our most recent member satisfaction survey, nearly ninety percent of respondents rated the…

Access key developments in pharmacy benefit compliance, ensuring that you have the knowledge and insights needed to deliver exceptional value to your clients in the ever-changing world of employee benefits. 

 When managing healthcare benefits, peace of mind comes from knowing that your clients receive the best care precisely when they need it. At Serve You Rx®, we believe in saying “yes” and delivering on that promise with flexibility, transparency, and a commitment to your success. Our Prior Authorization (PA) program is a great example of…

For nearly four decades, Serve You Rx has maintained consistent ownership and focused on organic growth, serving self-funded, mid-market employer groups. This steadfast approach sets us apart from many competitors and has allowed us to remain true to our founding mission. We are committed to collaborating closely with insurance brokers, benefit advisors, third-party administrators, and employer groups to reduce prescription drug costs and improve access to affordable medications.  

Serve You Rx announced the launch of its new Biosimilar Advantage Formulary. This formulary strategy, designed to accelerate the adoption of biosimilars, positions selected biosimilars with lower upfront costs as preferred treatments while holding reference brands as excluded or non-preferred. 

Implementing a new pharmacy benefit management (PBM) solution can be daunting, with numerous factors to consider and potential pitfalls to avoid. In this article, we’ll share the top 6 questions we receive about implementing new PBM groups and provide guidance based on our experience. 

The market is witnessing the emergence of more effective GLP-1s, with several new ones slated for release in 2026-2027, leading to an inevitable escalation of costs. The GLP-1 class continues to expand, with even more effective medications expected.

Access key developments in pharmacy benefit compliance, ensuring that you have the knowledge and insights needed to deliver exceptional value to your clients in the ever-changing world of employee benefits.